|
November 3, 2009
Goldman Sachs issued positive comments today on CVS Caremark Corporation (NYSE: CVS) ahead of earnings due on Nov 5, reiterating their Conviction Buy List rating and $40 price target. The firm sees EPS of $0.64, in-line with the consensus and at the high-end of co guidance; the firm sees the 2009 guidance range of $2.59-$2.64 to at least be maintained and possibly edged higher; and an update on the $2 billion share buyback, which could be approaching an end. Sentiment : Strong Buy Rating :
  (7 Ratings) |
Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
Messages in Topic
| Subject | Author | Rating | Time of Post (ET) | ||
|---|---|---|---|---|---|
|
Goldman Sachs Makes Positive Comments on CVS Ahead of ...
|
cash_tsunam... |
 
|
3-Nov-09 06:34 pm | ||
|
DID THET ASK ABOUT Amylin ?
DID THEY ASK THE CE...
|
nasdaq_penn... | (1 Rating) | 3-Nov-09 07:42 pm | ||
|
nasdaqph...
TOS for stalking
thanks for...
|
cash_tsunam... | (1 Rating) | 4-Nov-09 09:04 am |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
0.50